Price to Operating Profit (P/OP)
since 2018
Calculation
Moderna Inc., P/OP, long-term trends, calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Income (loss) from operations1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2024 | — | = | 96.46 | ÷ | -11.09 | -11.09 | = | -4,239 | ÷ | 382,073,208 | |
| Feb 24, 2023 | 5.71 | = | 139.26 | ÷ | 24.38 | 24.38 | = | 9,420 | ÷ | 386,339,594 | |
| Feb 25, 2022 | 4.59 | = | 151.33 | ÷ | 33.00 | 33.00 | = | 13,296 | ÷ | 402,872,986 | |
| Feb 26, 2021 | — | = | 154.81 | ÷ | -1.91 | -1.91 | = | -763 | ÷ | 399,769,582 | |
| Feb 27, 2020 | — | = | 26.16 | ÷ | -1.48 | -1.48 | = | -546 | ÷ | 368,642,548 | |
| Mar 13, 2019 | — | = | 19.97 | ÷ | -1.26 | -1.26 | = | -413 | ÷ | 329,000,469 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Moderna Inc. Annual Report.
Comparison to Competitors
Moderna Inc., P/OP, long-term trends, comparison to competitors
| Moderna Inc. | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|
| Feb 23, 2024 | — | 24.34 | 19.69 | 35.64 | 12.05 | 25.39 | 31.16 |
| Feb 24, 2023 | 5.71 | 14.78 | 13.40 | 20.97 | 14.21 | 18.01 | 25.30 |
| Feb 25, 2022 | 4.59 | 14.21 | 16.24 | 25.14 | 7.76 | 7.55 | 21.07 |
| Feb 26, 2021 | — | 16.32 | 14.96 | 36.91 | 19.38 | 14.82 | 22.81 |
| Feb 27, 2020 | — | 10.82 | 13.84 | 34.47 | 20.66 | 19.01 | 26.84 |
| Mar 13, 2019 | — | 18.35 | 11.46 | 23.18 | 10.15 | 17.53 | 27.33 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).